The design of safe and effective pharmaceuticals has benefitted greatly from advancements in organofluorine chemistry over recent decades. Because the properties of fluorine, such as its high electronegativity, unique lipophilicity, small size, and metabolic inertness, allow for the fine tuning of drug characteristics, ~25% of all drugs now contain at least one fluorine atom. This metric increases to 35%